Trinchieri A, Mandressi A, Luongo P, et al. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
Br J Urol. 1991;67:230 - 236.
Ruml LA, Pearle MS, Pak CY. Medical therapy, calcium oxalate urolithiasis.
Urol Clin North Am. 1997;24:117 - 133.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones.
Am J Epidemiol. 1996;143:240 - 247.
Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women.
Ann Intern Med. 1998;128:534 - 540.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Ruml LA, Pearle MS, Pak CY. Medical therapy, calcium oxalate urolithiasis.
Urol Clin North Am. 1997;24:117 - 133.
Trinchieri A, Mandressi A, Luongo P, et al. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
Br J Urol. 1991;67:230 - 236.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Ruml LA, Pearle MS, Pak CY. Medical therapy, calcium oxalate urolithiasis.
Urol Clin North Am. 1997;24:117 - 133.
Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis.
Urology. 2001;57:26 - 29.
Barcelo P, Wuhl O, Servitge E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
J Urol. 1993;150:1761 - 1764.
Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
J Urol.
1997;158:2069 - 2073.
Pak CY. Citrate and renal calculi: an update.
Miner Electrolyte Metab. 1994;20:371 - 377.
Pak CY. Citrate and renal calculi: an update.
Miner Electrolyte Metab. 1994;20:371 - 377.
Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
J Urol. 1996;156:907 - 909.
Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women.
Ann Intern Med. 1998;128:534 - 540.
Pak CY. Citrate and renal calculi: an update.
Miner Electrolyte Metab. 1994;20:371 - 377.
Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
J Urol.
1997;158:2069 - 2073.
Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
J Urol.
1997;158:2069 - 2073.
Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
J Urol.
1997;158:2069 - 2073.
Tatro D, ed.
Drug Interaction Facts.
St. Louis, Mo: Facts and Comparisons; 1999.
Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization.
J Urol.
1985;133:123 - 125.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Johansson G, Backman U, Danielson BG, et al. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.
J Urol. 1980;124:770 - 774.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Wilson DR, Strauss AL, Manuel MA. Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis.
Urol Res. 1984;12:39 - 40.
Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.
J Urol. 1988;139:679 - 684.
Johansson G, Backman U, Danielson BG, et al. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.
J Urol. 1980;124:770 - 774.
Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.
J Urol. 1988;139:679 - 684.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Murthy MS, Farooqui S, Talwar HS, et al. Effect of pyridoxine supplementation on recurrent stone formers.
Int J Clin Pharmacol Ther Toxicol. 1982;20:434 - 437.
Curhan GC, Willett WC, Speizer FE, et al. Intake of vitamins B6 and C and the risk of kidney stones in women.
J Am Soc Nephrol. 1999;10:840 - 845.
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men.
J Urol. 1996;155:1847 - 1851.
Blumenthal M, ed.
The Complete German Commission E Monographs, Therapeutic Guide to Herbal Medicines.
Boston, Mass: Integrative Medicine Communications; 1998:429.
Baggio B, Gambaro G, Marchini F, et al. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
Lancet. 1991;338:403 - 405.
Buck AC, Jenkins A, Lingam K, et al. The treatment of idiopathic recurrent urolithiasis with fish oil (EPA) and evening primrose oil (GLA) - a double blind study.
J Urol. 1993;149:253A.
Tulloch I, Smellie WS, Buck AC. Evening primrose oil reduces urinary calcium excretion in both normal and hypercalciuric rats.
Urol Res. 1994;22:227 - 230.
Bichler KH, Kirchner C, Weiser H, et al. Influence of vitamin A deficiency on the excretion of uromucoid and other substances in the urine of rats.
Clin Nephrol. 1983;20:32 - 39.
Gerster H. No contribution of ascorbic acid to renal calcium oxalate stones.
Ann Nutr Metab. 1997;41:269 - 282.
Traxer O, Adams-Huet B, Pak CY, et al. Risk of calcium oxalate stone formation with ascorbic acid ingestion. Presented at: American Urological Association 2001 Annual Meeting; June 2 - 7, 2001; Anaheim, Calif.
Curhan GC, Willett WC, Speizer FE, et al. Intake of vitamins B6 and C and the risk of kidney stones in women.
J Am Soc Nephrol. 1999;10:840 - 845.
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men.
J Urol. 1996;155:1847 - 1851.
Simon JA, Hudes ES. Relation of serum ascorbic acid to serum vitamin B12, serum ferritin, and kidney stones in US adults.
Arch Intern Med. 1999;159:619 - 624.
Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.
Eur J Clin Invest. 1998;28:695 - 700.
Gerster H. No contribution of ascorbic acid to renal calcium oxalate stones.
Ann Nutr Metab. 1997;41:269 - 282.
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones.
N Engl J Med. 1993;328:833 - 838.
Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women.
Ann Intern Med. 1997;126:497 - 504.
Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease.
J Urol. 1996;155:432 - 440.
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.
N Engl J Med. 2002;346:77 - 84.
Iguchi M, Katoh Y, Koike H, et al. Randomized trial of trigger point injection for renal colic.
Int J Urol. 2002;9:475 - 479.
Heller HJ, Doerner MF, Brinkley LJ, et al. Effect of dietary calcium on stone forming propensity.
J Urol. 2003;169:470 - 474.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.